Annals of Clinical and Translational Neurology

Article	Citations
Genetic Profile and Symptom Pattern Explain Variability of Deep Brain Stimulation Effect in Dystonia	115
The case of a 49‐year‐old man with involuntary toe movements	98
Issue Information	77
Clinical variability associated with intronic FGF14 GAA repeat expansion in Japan	74
Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes	64
Muscle magnetic resonance imaging involvement patterns in nemaline myopathies	61
Cognitive impairment in pulmonary arterial hypertension	60
Refractory myasthenia gravis treated with autologous hematopoietic stem cell transplantation	59
Exhaustive clinical examination of etiology and initial response to first‐line treatment in 577 children with infantile epileptic spasm syndrome children: A 5‐year retrospective observational study	58
Structural and functional connectivity alteration patterns of the cingulate gyrus in Type 2 diabetes	57
Discrepant expressive language lateralization in children and adolescents with epilepsy	46
Brain imaging signatures in amyotrophic lateral sclerosis: Correlation with peripheral motor degeneration	44
Focal lesions following intracerebral gene therapy for mucopolysaccharidosis IIIA	42
Blended phenotype of TECPR2‐associated hereditary sensory‐autonomic neuropathy and Temple syndrome	42
Alemtuzumab treatment for multiple sclerosis in Austria: An observational long‐term outcome study	40
Order from chaos: Using CSF proteomics to predict ALS progression	39
High‐dose IgG suppresses local inflammation and facilitates functional recovery after olfactory system injury	38
Association of serum Spp1 levels with disease progression in ALS and SBMA	38
Consistency of electrical source imaging in presurgical evaluation of epilepsy across different vigilance states	38
Epitope Mapping of Anti‐Neurofascin 155 Antibody in a Large Cohort of Autoimmune Nodopathy Patients	38
Peripheral nervous system manifestations of MOG antibody associated disease	37
Late‐onset Krabbe disease presenting as spastic paraplegia – implications of GCase and CTSB/D	36
Plasma exchange with albumin replacement for Alzheimer's disease treatment induced changes in serum and cerebrospinal fluid inflammatory mediator levels	36
SARS‐CoV‐2 Is Linked to Brain Volume Loss in Multiple Sclerosis	36
Cocaine use is associated with cerebral white matter hyperintensities in HIV disease	35

The Case of a 25‐Year‐Old Woman With Isolated Head Tremor	35
ALS plasma biomarkers reveal neurofilament and pTau correlate with disease onset and progression	34
Incremental clinical value of intraplaque neovascularization in predicting recurrent ischemic stroke	34
SNUPN‐Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights	34
Issue Information	33
Cerebellar impulsivity–compulsivity assessment scale	33
Diagnostic Challenge in Frontal Variant Alzheimer's Disease With Low Amyloid‐β PET Retention	32
Functional Connectivity Associations With Markers of Disease Progression in GRN Pathogenic Variant Carriers	31
Plasma p‐tau181 as a Marker of Conversion to Alzheimer's Disease Dementia and Worsening in Cognitive Functions in Subjective Cognitive Decline and Mild Cognitive Impairment: A Longitudinal Study	31
Predictors of mTICI 2c/3 over 2b in patients successfully recanalized with mechanical thrombectomy	30
Long‐Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons	30
Plasma β‐synuclein, GFAP, and neurofilaments in patients with malignant gliomas undergoing surgical and adjuvant therapy	30
Early spinal muscular atrophy treatment following newborn screening: A 20‐month review of the first Italian regional experience	30
A potential biomarker of cognitive impairment: The olfactory dysfunction and its genes expression	29
Genome and RNA sequencing boost neuromuscular diagnoses to 62% from 34% with exome sequencing alone	29
The case of a 60‐year‐old man with decline in job performance and changes in personality and judgment	29
Cerebral Amyloid Angiopathy Is Associated With Higher R2 Relaxation Rate: An MRI and Pathology Study	29
Corrigendum: Genome sequencing in persistently unsolved white matter disorders	29
Expanding Hereditary Spastic Paraplegias Limits: Biallelic SPAST Variants in Cerebral Palsy Mimics	29
Dose–exposure–efficacy response of intravenous immunoglobulin G 10% in multifocal motor neuropathy	29
Comparison between mono‐tacrolimus and mono‐glucocorticoid in the treatment of myasthenia gravis	28
Clinicoserological insights into patients with immune checkpoint inhibitor‐induced myasthenia gravis	28
Correlation of slow‐wave sleep with motor and nonmotor progression in Parkinson's disease	28
Clinical scales in autoimmune encephalitis—A retrospective monocentric cohort study	28
Prolonged venous transit is associated with worse neurological recovery in successfully reperfused large vessel strokes	27
Association between air pollution and CSF sTREM2 in cognitively normal older adults: The CABLE study	26
Intracranial plaque with large lipid core is associated with embolic stroke of undetermined source	26
Visceral and emotional responses to direct electrical stimulations of the cortex	26
Exosomal circ‐AHCY promotes glioblastoma cell growth via Wnt/β‐catenin signaling pathway	26
Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD)	26
COVID‐19 and the risk of Alzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosis	25
Vascular endothelial‐cadherin as a marker of endothelial injury in preclinical Alzheimer disease	25
Epidural stimulation with locomotor training ameliorates unstable blood pressure after tetraplegia. A case report	25
Cortical networks of parkinsonian gait: a metabolic and functional connectivity study	25
Issue Information	25
Issue Information	24
The systemic inflammation markers as possible indices for predicting respiratory failure and outcome in patients with myasthenia gravis	24
Laser interstitial thermal therapy in the management of bottom‐of‐sulcus dysplasia‐related epilepsy	24
Progressive Myoclonus Epilepsy: Distinctive MRI Changes in Cerebellar and Motor Networks	23
Autoimmune brainstem encephalitis: Clinical associations, outcomes, and proposed diagnostic criteria	23
Clinical utility of diffusion MRI‐derived measures of cortical microstructure in a real‐world memory clinic setting	23
Intrinsic and extrinsic contributors to subregional thalamic volume loss in multiple sclerosis	23
Retina as a potential biomarker for the early stage of Alzheimer's disease spectrum	23
Identification of potential biomarkers for neuromyelitis optica by quantitative proteomics	23
Transcranial pulse stimulation in the treatment of mild neurocognitive disorders	23
Horizontal gaze palsy with progressive scoliosis: Further expanding the ROBO3 spectrum	23
Topiramate dosage optimization for effective antiseizure management via population pharmacokinetic modeling	22
CSF cytokine, chemokine and injury biomarker profile of glial fibrillary acidic protein (GFAP) autoimmunity	22
Issue Information	22
TRPV4 mutations causing mixed neuropathy and skeletal phenotypes result in severe gain of function	22

Issue Information	22
Characteristics of Cerebral Palsy in the Midwestern US	22
Plasma GFAP associates with secondary Alzheimer's pathology in Lewy body disease	21
Adult‐onset rapidly worsening progressive myoclonic epilepsy caused by a novel variant in DHDDS	21
Issue Information	21
Comprehensive assessment reveals numerous clinical and neurophysiological differences between MECP2‐allelic disorders	21
Safety and patient experience with at‐home infusion of ocrelizumab for multiple sclerosis	20
Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophy	20
Machine learning models for outcome prediction in thrombectomy for large anterior vessel occlusion	20
Circulating Interleukin‐6 Levels and Timing of Acute Ischemic Stroke Onset	20
Cerebello‐Prefrontal Connectivity Underlying Cognitive Dysfunction in Spinocerebellar Ataxia Type 2	20
Intravenous tirofiban following successful reperfusion in intracranial large artery atherosclerotic stroke: A secondary analysis of a randomized clinical trial	19
The case of an 85‐year‐old female with acute right hemiparesis with status epilepticus	19
Comparison of plasma and CSF biomarkers in predicting cognitive decline	19
Quantity and Volume of Perivascular Spaces Are Inversely Associated With Multiple Sclerosis Relative to Cerebrovascular Disease and Migraine	19
Effects of Non‐Aspirin Nonsteroidal Anti‐Inflammatory Drugs on Acute Intracerebral Hemorrhage	19
A PANoptosis‐Based Signature for Survival and Immune Predication in Glioblastoma Multiforme	19
A novel autosomal dominant ERLIN2 variant activates endoplasmic reticulum stress in a Chinese HSP family	19
Recurring homozygous ACTN2 variant (p.Arg506Gly) causes a recessive myopathy	19
Tau maturation in the clinicopathological spectrum of Lewy body and Alzheimer's disease	19
Modifiable factors associated with Huntington's disease progression in presymptomatic participants	19
Voxel‐based dysconnectomic brain morphometry with computed tomography in Down syndrome	18
Genetic Diversity and Expanded Phenotypes in Dystonia: Insights From Large‐Scale Exome Sequencing	18
Temporal lobe epilepsy surgery: Piriform cortex resection impacts seizure control in the long‐term	18
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis	18
Altered Dynamic Functional Network Connectivity in Post‐Stroke Aphasia	18
The Comparative Effectiveness and Tolerability of Sphingosine‐1‐Phosphate Receptor Modulators in Patients With Multiple Sclerosis: A Network Meta‐Analysis of Randomized Controlled Trials	18
Liraglutide for idiopathic intracranial hypertension: a real‐world propensity score‐matched study	18
Longitudinal analysis of peripheral immune cells in patients with multiple sclerosis treated with anti‐CD20 therapy	18
Quantitative determination of SLC2A1 variant functional effects in GLUT1 deficiency syndrome	18
Ser77Tyr transthyretin amyloidosis in Israel: Initial manifestations and diagnostic features	17
RETRACTION: Mechanism of ARPP21 antagonistic intron miR‐128 on neurological function repair after stroke	17
	17
Phenotyping Healthcare Use 2–3 Decades Before the First Multiple Sclerosis Demyelinating Event	17
Mutation and clinical analysis of the CLCC1 gene in amyotrophic lateral sclerosis patients from Central South China	17
Exercise training alters autoimmune cell invasion into the brain in autoimmune encephalomyelitis	17
Issue Information	17
	17
CIDP/autoimmune nodopathies with nephropathy: a case series study	17
Relation of CDC42, Th1, Th2, and Th17 cells with cognitive function decline in Alzheimer's disease	17
A machine learning approach to predict quality of life changes in patients with Parkinson's Disease	17
Correction to “Neurofilament light chain levels in cerebrospinal fluid as a sensitive biomarker for cerebral adrenoleukodystrophy”	17
Longitudinal serum neurofilament light kinetics in post‐anoxic encephalopathy	17
Real‐world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis	17
Ethnoracial disparities in gray matter atrophy are mediated by structural disconnectivity in multiple sclerosis	17
Effects of sulfatide on peripheral nerves in metachromatic leukodystrophy	16
Infliximab in neurosarcoidosis: a systematic review and meta‐analysis	16
Power training alters somatosensory cortical activity of youth with cerebral palsy	16
Benchmarking the proteomic profile of animal models of mesial temporal epilepsy	16
Chronic Pain in Parkinson’s Disease: Prevalence, Sex Differences, Regional Anatomy and Comorbidities	16
Lesion Location and Functional Connections Reveal Cognitive Impairment Networks in Multiple Sclerosis	16
A different pattern of clinical, muscle pathology and brain MRI findings in MELAS with mt‐ND variants	16
Nanopore 16S sequencing enhances the detection of bacterial meningitis after neurosurgery	15
Differential impact on motor unit characteristics across severities of adult spinal muscular atrophy	15
Non‐neurological factors associated with serum neurofilament levels in the United States population	15
	15
Tofersen treatment leads to sustained stabilization of disease in SOD1 ALS in a “real‐world” setting	15
NR4A1 Exerts Pro‐Tumor Role in Glioblastoma via Inducing xCT/GPX4‐Regulated Ferroptosis	15
Remyelination varies between and within lesions in multiple sclerosis following bexarotene	15
Mitochondrial dysfunction in brain tissues and Extracellular Vesicles Fragile X‐associated tremor/ataxia syndrome	15
Clinical, genetic, and molecular characteristics in a central‐southern Chinese cohort of genetic leukodystrophies	15
Innovative technology‐based interventions in Parkinson's disease: A systematic review and meta‐analysis	15
LRRK2 and Parkinson's disease: from genetics to targeted therapy	15
	15
A 14‐Year Study of Serum Glial Fibrillary Acidic Protein and Total Tau in Premanifest Huntington's	15
Dual‐Phase C‐11 PiB PET Images for Detecting Tau Pathology in Cerebral Amyloid Angiopathy	14
“Brain age” predicts disability accumulation in multiple sclerosis	14
Evolution of neurologic symptoms in non‐hospitalized COVID‐19 “long haulers”	14
Onasemnogene‐abeparvovec administration to premature infants with spinal muscular atrophy	14
Argatroban plus alteplase in posterior versus anterior circulation stroke	14
Exploring if Longitudinal Changes on PET Imaging Can Serve as a Biomarker for Stiff Person Syndrome Spectrum Disorders	14
Bilateral versus Unilateral Training With Rhythmic Auditory Cueing in Stroke Rehabilitation: Effects on Upper Limb Function and Interhemispheric Inhibition	14
Occurrence, Risk Factors, and Prognosis of Acute Cerebral Microinfarcts in CADASIL	14
Chitotriosidase is a biomarker for adult‐onset leukoencephalopathy with axonal spheroids and pigmented glia	14
Distinctive cell‐free DNA methylation characterizes presymptomatic genetic frontotemporal dementia	14
Scientific rationale for a higher dose of nusinersen	14
Safety, pharmacokinetics, and pharmacodynamics of nomlabofusp (CTI‐1601) in Friedreich's ataxia	14
Patient Selection in Deep Brain Stimulation: A Role for Transcranial Direct Current Stimulation to Enhance the Levodopa Challenge?	14
Longitudinal changes of SARA scale in Friedreich ataxia: Strong influence of baseline score and age at onset	14
After early mTICI 2b, stop or continue? Insights from the PERSIST Registry	14

Management and Outcomes in Confirmed or Suspected Acute Symptomatic Seizure: Role of Structured Outpatient Care	14
4‐Octyl itaconate inhibits inflammation via the NLRP3 pathway in neuromyelitis optica spectrum disorders	14
Observational study of medical marijuana as a treatment for treatment‐resistant epilepsies	14
A machine‐learning approach for predicting impaired consciousness in absence epilepsy	14
Recognizing early MRI signs (or their absence) is crucial in diagnosing metachromatic leukodystrophy	14
The Road Not Taken: Misclassifying an Anti‐Seizure Medication as a Failure	14
Pupillary dynamics predict long‐term outcome in a cohort of acute traumatic brain injury coma patients	14
Upregulation of RCAN1.4 by HIF1α alleviates OGD‐induced inflammatory response in astrocytes	14
Optical genome mapping: Unraveling complex variations and enabling precise diagnosis in dystrophinopathy	14
Odor identification predicts the transition of patients with isolated RBD: A retrospective study	13
Glycated hemoglobin A1c, cerebral small vessel disease burden, and disease severity in Parkinson's disease	13
WiTNNess: An international natural history study of infantile‐onset TNNT1 myopathy	13
Endovascular thrombectomy versus medical management on outcomes with infarct volumes more than 70 mL	13
Long‐term safety and efficacy of stenting on correcting internal jugular vein and cerebral venous sinus stenosis	13
Well‐being on supportive techniques in amyotrophic lateral sclerosis: from neurologists' perspective	13
Heart meets brain: A 25‐year‐old with a constellation of neurologic symptoms and heart failure	13
Natural history and survival rate of familial amyloidosis with polyneuropathy: A nationwide databank	13
Downregulation of SF3B2 protects CNS neurons in models of multiple sclerosis	13
Phase 1, First‐In‐Human, Single‐/Multiple‐Ascending Dose Study of Iluzanebart in Healthy Volunteers	13
Durable B‐Cell Impairment While Sparing IgA B Cells After Ocrelizumab Therapy in Multiple Sclerosis	13
SCAR32: Functional characterization and expansion of the clinical‐genetic spectrum	13
T1−/T2‐weighted ratio reveals no alterations to gray matter myelination in temporal lobe epilepsy	13
Using electronic health data to explore effectiveness of ICU EEG and anti‐seizure treatment	12
Safety and efficacy of intravenous thrombolytic therapy in the extended window up to 24 hours: A systematic review and meta‐analysis	12
Neurological diagnoses in hospitalized COVID‐19 patients during the B.1.1.529 surge	12
Drug‐refractory myasthenia gravis: Clinical characteristics, treatments, and outcome	12
Novel Phenotypes and Deep Intronic Variant Expand TH‐Associated Dopa‐Responsive Dystonia Spectrum	12
Baseline systolic blood pressure, hypertension history, and efficacy of remote ischemic conditioning	12
Characterizing mortality in patients with AQP4‐Ab+ neuromyelitis optica spectrum disorder	12
Psychotropic medication use and Parkinson's disease risk amongst older women	12
B cell and aquaporin‐4 antibody relationships with neuromyelitis optica spectrum disorder activity	12
Correction to “Efgartigimod for Generalized Myasthenia Gravis: A Multicenter Real‐World Cohort Study in China”	12
Spatiotemporal spinal cord stimulation with real‐time triggering exoskeleton restores walking capability: a case report	12
Sensitivity and specificity of the Salzburg EEG criteria for nonconvulsive status epilepticus	12
Clinicopathological and circulating cell‐free DNA profile in myositis associated with anti‐mitochondrial antibody	11
First‐ever acute ischemic strokes in HIV‐infected persons: A case–control study from stroke units	11
Lipid levels and the risk of dementia: A dose–response meta‐analysis of prospective cohort studies	11
The Impact of Tilburg Frailty on Poststroke Fatigue in First‐Ever Stroke Patients: A Cross‐Sectional Study With Unified Measurement Tools and Improved Statistics	11
Adult‐onset leukoencephalopathy caused by CSF1R mutations: Is all that glitters gold?	11
CD163+ macrophage density in perimysial connective tissue associated with prognosis in IMNM	11
Cortical signature of depressive symptoms in frontotemporal dementia: A surface‐based analysis	11
Emerging variants, unique phenotypes, and transcriptomic signatures: an integrated study of COASY‐associated diseases	11
Long COVID in People With Multiple Sclerosis and Related Disorders: A Multicenter Cross‐Sectional Study	11
An MRI assessment of mechanisms underlying lesion growth and shrinkage in multiple sclerosis	11
SARS‐COV‐2 a trigger of myelin oligodendrocyte glycoprotein‐associated disorder	11
Repeated iv anti‐CD20 treatment in multiple sclerosis: Long‐term effects on peripheral immune cell subsets	11
Erratum to “Inferring Disease Course From Differential Exon Usage in the Wide Titinopathy Spectrum”	11
Optimized microburst VNS elicits fMRI responses beyond thalamic‐specific response from standard VNS	11
Genetic spectrum in a cohort of patients with distal hereditary motor neuropathy	11
B‐cell depletion limits HTLV‐1‐infected T‐cell expansion and ameliorate HTLV‐1‐associated myelopathy	11
Women's reproductive traits and ischemic stroke: a two‐sample Mendelian randomization study	11
Impact of lipid profiles on parenchymal hemorrhage and early outcome after mechanical thrombectomy	11
Issue Information	11
Evaluating brain damage in multiple sclerosis with simultaneous multi‐angular‐relaxometry of tissue	11
	11
Capturing what matters: Patient‐reported LGI1‐ANTibody encephalitis outcome RatiNg scale (LANTERN)	11
Psoriasis and dementia: A population‐based matched cohort study of adults in England	11
ADAPT NXT: Fixed Cycles or Every‐Other‐Week IV Efgartigimod in Generalized Myasthenia Gravis	11
Observational Study of Tocilizumab in Children With Febrile Infection‐Related Epilepsy Syndrome	10
Before attributing encephalomyelitis to SARS‐CoV‐2 vaccinations thoroughly exclude differentials	10
Amyloidogenicity assessment of transthyretin gene variants	10
Calcium modulating ligand confers risk for Parkinson's disease and impacts lysosomes	10
Axonal injury, sleep disturbances, and memory following traumatic brain injury	10
Disorder of consciousness: Structural integrity of brain networks for the clinical assessment	10
Does long‐term phenytoin have a place in Dravet syndrome?	10
Interaction between sex and neurofilament light chain on brain structure and clinical severity in Huntington’s disease	10
Blood–brain barrier profile pretreatment is associated with hemorrhagic transformation after endovascular reperfusion	10
The Diverse Neuromuscular Spectrum of VPS13A Disease	10
Seroprevalence of anti‐myelin oligodendrocyte glycoprotein antibodies in adults with myelitis	10
CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia	10
Homozygous variant in COQ7 causes autosomal recessive hereditary spastic paraplegia	10
White matter microstructures in Parkinson's disease with and without impulse control behaviors	10
Efficacy and safety of combined low‐dose rituximab regimen for chronic inflammatory demyelinating polyradiculoneuropathy	10
Social impact of brain fog and analysis of risk factors: Long COVID in Japanese population	10
Transcriptome analysis of collagen VI‐related muscular dystrophy muscle biopsies	10
Precision‐Optimised Post‐Stroke Prognoses	10
The neural correlates of topographical disorientation—a lesion analysis study	10
Associative cued asynchronous BCI induces cortical plasticity in stroke patients	10
Pharmacological perturbation reveals deficits in D2 receptor responses in Thap1 null mice	10
Music Interventions in Hyperacute and Acute Stroke Patients: A Randomized Controlled Pilot Feasibility Study	10
Combination disease‐modifying treatment in spinal muscular atrophy: A proposed classification	10
Issue Information	10
Issue Information	10
Clinical characteristics of double negative atypical inflammatory demyelinating disease: A prospective study	10
Efficacy of melatonin in term neonatal models of perinatal hypoxia‐ischaemia	10
Association of the time of day of EVT with clinical outcomes and benefit from successful recanalization after stroke	10
Using chronic recordings from a closed‐loop neurostimulation system to capture seizures across multiple thalamic nuclei	10
Quantitative magnetic resonance neurography in chronic inflammatory demyelinating polyradiculoneuropathy: A longitudinal study over 6 years	9
An Analysis for IDH‐Mutant Grade 4 Astrocytoma Based on WHO CNS 5: Implication of Clinical Practice	9
LINC00323 variant is associated with increased risk of essential tremor	9
Reply to Letter: “Real‐World Clinical Experience With Serum MOG and AQP4 Antibody Testing by Live Versus Fixed Cell‐Based Assay”	9
Parkinsonism‐dystonia‐2: Case‐series study from Saudi Arabia	9
Detecting rs‐fMRI Networks in Disorders of Consciousness: Improving Clinical Interpretability	9
Correlation Between Irisin and Cognitive Functions in Alzheimer Dementia	9
Issue Information	9